Epidemiology, oncologic results and risk stratification model for metachronous peritoneal metastases after surgery for pT4 colon cancers: results from an observational retrospective multicentre long-term follow-up study.
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Cerdán-Santacruz C
- Cano-Valderrama Ó
- Peña Ros E
- Serrano Del Moral Á
- Pereira Pérez F
- Biondo S
- Collaborating group for the study of metachronous peritoneal metastases of pT4
Grupos
Abstract
PURPOSE: Metachronous peritoneal metastases (MPM) following a curative surgery procedure for pT4 colon cancer is a challenging condition. Current epidemiological studies on this topic are scarce. METHODS: A retrospective multicentre trial was designed. All consecutive patients who underwent operations to treat pT4 cancers between 2015 and 2017 were reviewed. Demographic, clinical, operative, pathological and oncological follow-up variables were included. MPM were described as any oncological disease at the peritoneum, clearly different from a local recurrence. Univariate and multivariate Cox regression models were constructed. A risk stratification model was created on a cumulative factor basis. According to the calculated hazard ratio (HR), a scoring system was designed (HR < 3, 1 point; HR > 3, 2 points) and a scale from 0 to 6 was calculated for peritoneal disease-free rate (PDF-R). A risk stratification model was also created on the basis of these calculations. RESULTS: Fifty different hospitals were involved, which included a total of 1356 patients. Incidence of MPM was 13.6% at 50 months median follow-up. The strongest independent risk factors for MPM were positive pN stage [HR 3.72 (95% CI 2.56-5.41; p < 0.01) for stage III disease], tumour perforation [HR 1.91 (95% CI 1.26-2.87; p < 0.01)], mucinous or signet ring cell histology [HR 1.68 (95% CI 1.1-2.58; p = 0.02)], poorly differentiated tumours [HR 1.54 (95% CI 1.1-2.2; p = 0.02)] and emergency surgery [HR 1.42 (95% CI 1.01-2.01; p = 0.049)]. In the absence of additional risk factors, pT4 tumours showed 98% and 96% PDF-R in 1-year and 5-year periods based on Kaplan-Meier curves. CONCLUSIONS: Cumulative MPM incidence was 13.6% at 5-year follow-up. The sole presence of a pT4 tumour resulted in high rates of PDF-R at 1-year and 5-year follow-up (98% and 96% respectively). Five additional risk factors different from pT4 status itself were identified as possible MPM indicators during follow-up.
© 2023. Springer Nature Switzerland AG.
Datos de la publicación
- ISSN/ISSNe:
- 1123-6337, 1128-045X
- Tipo:
- Article
- Páginas:
- 1025-1036
- Factor de Impacto:
- 0,809 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
TECHNIQUES IN COLOPROCTOLOGY SPRINGER-VERLAG ITALIA SRL
Documentos
- No hay documentos
Filiaciones
Keywords
- Colon cancer; HIPEC; Metachronous peritoneal metastases; Risk stratification; Second look
Proyectos asociados
Ileostomía vistual combinada con endoscopia postoperatoria ebn cáncer de recto con escisión total mesorrectal. ¿podemos evitar estomas innecesarios? estudio prospectivo observacional multicénctrico.
Investigador Principal: BLAS FLOR LORENTE
PI17/00863 . INSTITUTO DE SALUD CARLOS III . 2018
"TIMing Evaluation of Stoma closure” Cierre precoz vs tardío del estoma derivativo tras cirugía de cáncer de recto.
Investigador Principal: MATTEO FRASSON
2018_0078_CRC_FRASSON . ASOCIACIÓN ESPAÑOLA DE COLOPROCTOLOGÍA (AECP) . 2018
Trocar multisensor para cirugía laparoscópica con presión de pneumoperitoneo individualizada
Investigador Principal: ÓSCAR DÍAZ CAMBRONERO
INNVAL10/18/056 . AGENCIA VALENCIANA DE LA INNOVACION (AVI) . 2018
INDIVIDUALIZED PERIOPERATIVE HEMODYNAMIC GOAL-DIRECTED THERAPY IN MAJOR ABDOMINAL SURGERY (IPEGASUS-TRIAL).
Investigador Principal: ÓSCAR DÍAZ CAMBRONERO
IPEGASUS . 2017
MU OPIOID RECEPTOR 1 (MOR-1) EXPRESSION IN COLORECTAL CANCER AND DISEASE-FREE SURVIVAL RELATIONSHIP (MOROCCO). FIVE-YEAR FOLLOW-UP.
Investigador Principal: ÓSCAR DÍAZ CAMBRONERO
ODC-MOR-2018-01
PRESIÓN INDIVIDUALIZADA DE INSUFLACIÓN DEL PNEUMOPERITONEO EN CIRUGÍA LAPAROSCÓPICA COLORECTAL FRENTE A TERAPIA ESTÁNDAR.
Investigador Principal: ÓSCAR DÍAZ CAMBRONERO
IPPCOLLAPSE-II . 2016
Acute PresentatiOn of CoLorectaL Cancer: an internatiOnal snapshot An international, multi-centre study of emergency presentations of colorectal cancer.
Investigador Principal: JORGE SANCHO MURIEL
APOLLO . 2023
HEMO-FISSQoL - Traducción validada al español de un instrumento de medida de la calidad de vida en pacientes con patología hemorroidal y fisura anal.
Investigador Principal: HANNA BARBARA CHOLEWA
HEMO-FISSQoL . 2023
Estudio de seguimiento clínico poscomercialización de los dispositivos de aplicación de clips reutilizables y cartuchos para cirugía laparoscópica (RELAP).
Investigador Principal: ÓSCAR DÍAZ CAMBRONERO
PD01-227 . 2023
Resección de tumor rectal mediante el dispositivo de acceso transanal multicanal UNI-VEC.
Investigador Principal: BLAS FLOR LORENTE
vec-pr-1901 . 2023
Cita
Cerdán C,Cano Ó,Peña E,Serrano Del Moral Á,Pereira F,Flor B,Biondo S,Collaborating group for the study of metachronous peritoneal metastases of PT4. Epidemiology, oncologic results and risk stratification model for metachronous peritoneal metastases after surgery for pT4 colon cancers: results from an observational retrospective multicentre long-term follow-up study. Tech Coloproctol. 2023. 27. (11):p. 1025-1036. IF:2,700. (1).